Recent data suggest that STEAP1 additionally represents an attractive target for antibody-based immunotherapy as two STEAP-specific mAbs significantly inhibited the growth of PCa xenografts in mice [114]. This evidence concerns the gene STEAP1 and posterior cortical atrophy.